Facility Introduction

G2GBIO possesses its own GMP capable of producing clinical trial IP, which enables rapid conduction of clinical trials for various long-acting microsphere injectables

Standards-Compliant Facility
GMP-Compliant Facility
Capable of manufacturing variouslong-acting microsphere injectables
Using our proprietary InnoLAMP technology platform, our manufacturing facility is capable of producing long-acting microsphere injectables applying a variety of APIs.
Ensuring quality uniformity through automated processes
Minimizing human error and ensuring quality uniformity through the application of automated processes
Production capability andquality system secured
Production capability and quality system for early commercial production secured

GMP internal facility